DUR system in Jeju hit by new flu?

Published: 2009-11-05 06:59:00

Updated: 2009-11-05 06:59:00

The second Drug Utilization Review (DUR) system was implemented from November 2 on a trial basis, but it could not be properly conducted as planned as the government raised the H1N1 flu alert to its highest level, pledging all-out efforts against the further spread of the disease throughout the n...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK